{"id":325236,"date":"2026-10-23T13:26:36","date_gmt":"2026-10-23T07:56:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=325236"},"modified":"2026-10-23T13:26:36","modified_gmt":"2026-10-23T07:56:36","slug":"tonbo-imaging-vs-zetwerk-vs-bonfiglioli-vs-sahajanand-medical-listing-day-share-price-who-won-debut-race-on-nse-bse","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/tonbo-imaging-vs-zetwerk-vs-bonfiglioli-vs-sahajanand-medical-listing-day-share-price-who-won-debut-race-on-nse-bse\/","title":{"rendered":"IPO Listings Today: Tonbo Imaging vs Zetwerk vs Bonfiglioli vs Sahajanand, Who Won the Debut Race on NSE and BSE?"},"content":{"rendered":"

IPO listings on 23 Oct 2026 had one clear winner: Tonbo Imaging listed at Rs 1,162 on BSE, a premium of 66% over its Rs 700 issue price. Sahajanand Medical listed at about 7% to 8% above Rs 344 and Zetwerk about 5% above Rs 151, while Bonfiglioli listed flat at Rs 586. By about 1:15 PM Tonbo was up 52.9% from issue price, Sahajanand up 8.1%, Bonfiglioli down 0.4% and Zetwerk down 11.8%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

IPO listings today were led by Tonbo Imaging, which opened at Rs 1,160 on NSE and Rs 1,162 on BSE against an issue price of Rs 700, a premium of about 66%. Sahajanand Medical Technologies and Zetwerk gained modestly on listing, and Bonfiglioli Transmissions listed flat at its issue price of Rs 586. At about 1:15 PM, Tonbo was Rs 1,070.15, Sahajanand Rs 371.90, Bonfiglioli Rs 583.75 and Zetwerk Rs 133.15, which is below its issue price. These are intraday prices and they can change by the close.<\/p>\n<\/p><\/div>\n

IPO listings rarely come in a group of four, and the four issues together raised about Rs 8,873 crore in the 15 to 19 Oct window. Comparing these IPO listings side by side shows how differently the market treated each one, even though all four were oversubscribed.<\/p>\n

This article on IPO listings covers the issue and listing prices, live prices, the profit or loss per lot, the subscription numbers and the lessons from the debut day. It is educational and not a recommendation to buy or sell.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n